Background: Acinetobacterbaumannii is a negative gram opportunistic bacteriumhaving high survival ability in the environment. Carbapenem is a drug of choice for infections caused by Acinetobacterbaumannii, which in the last decade prevalence of Carbapenem Resistant Acinetobacterbaumannii (CRAB) has increased. CRAB is commonly found in a nosocomial infection case and even into disease outbreak and epidemics in various hospitals. However, CRAB in community-associated infection data is still limited primarily in Indonesia. Therefore the researchers intend to do study factors causing CRAB in hospital and community setting in patients with Healthcare Associated Infection (HCAI). Subjects and Method: This study was an observational analytic study, with case control design. The study was conducted in RS Dr. Moewardi Surakarta in March-August 2017. Taking subject used fixed disease sampling method with the number of samples were 104 subjects. The dependent variable was the incidence of Acinetobacterbaumannii resistance to carbapenem antibiotics in HCAI patients. Independent variables were history of antibiotic use, patient functional status, intensive unit maintenance and comorbid conditions. Dependent and independent variables were measured by using a questionnairechecklist and then analyzed by using multiple logistic regression analysis. Results: Previous antibiotic conformity history (OR = 0.12; 95% CI = 0.03 to 0.45; p = 0.002) and the patient functional status (OR = 6.72; 95% CI = 2.08 to 21.68; p = 0.001) increased risk of resistance of Acinetobacterbaumannii to carbapenem (CRAB) in Healthcare-Associated Infections (HCAI) patients and was statistically significant. Treatment at intensive unit (OR = 0.76; 95% CI = 0.26 to 2.23; p = 0.613) and comorbid conditions (OR = 0.38; 95% CI = 0.12 to 1.23; p = 0.106) increased risk of Acinetobacterbaumannii resistance to carbapenem (CRAB) in Healthcare Associated Infections (HCAI) patients although it was statistically insignificant. Conclusion:Previous antibiotic conformity history and functional status of patients are a factor affecting Acinetobacterbaumannii resistance to carbapenem (CRAB) in Healthcare-Associated Infections (HCAI) patients.
later an England doctor reported that there had been resistance to Staphylococcus pyogens bacteria against penicillin (Schechner et al. 2013) .
AMR can occur if it begins with irrational use of antibiotics, both in the therapy terms (doctor) and in the consumer distribution (pharmacy) and when received by the patient (Moeloek, 2015; WHO, 2016b) . AMR cases in the United States resulted in death at least 23,000 people and in Europe at least 25,000 people per year (Lim et al., 2016) . According to WHO data, Southeast Asian holds the highest number of AMR cases in the world. Indonesia as a member of the Southeast Asian country also takes the AMR case seriously, but surveillance data related to AMR mortality and morbidity in the field are still very limited (Moeloek, 2015) .
One of the bacteria that cause AMR is Acinetobacterbaumannii. These bacteria are gram-negative bacteria that can be found in many places, such as on soil, water, human skin surfaces, equipment and hospital floor (Tjoaet al., 2013) . A. baumannii is also an opportunistic bacterium whose pathogenicity is low, but over the time, these bacteria have high pathogenic capability because they have become resistant bacteria not only on one type of antibiotics but also on several types of antibiotics (Multi Drugs Resistance/ MDR) Adibhesamiet al., 2016; Garnacho Montero et al., 2016) and has been reported to have both Panresistance and Extremely Drug Resistance Acinetobacterbaumannii (XDRAB).
MDR A. Baumannii is a cause of increasing patient mortality and morbidity as well as length of hospitalization, the increase in patient mortality due to A. Baumannii is 17-46% (Tjoa et al., 2103) . Some of the diseases often caused by A. Baumannii are ventilator associated pneumonia, urinary tract infections and surgical wounds, meningitis and endocarditis (Lei et al., 2016) . The existence of infection due to MDR A. baumannii makes the therapy choice narrower, increases mortality and morbidity, as well as increases cost and length of hospitalization, and makes it one of the important public health issues to be solved immediately (Chang et al. 2015; Tjoa et al., 2013) .
Healthcare Associated Infections (HCAI) is an infection acquired in hospitalized patients over 48 hours with a history of previous hospital care (within 90 days) or receiving treatment (open wound, intravenous injection or intravenous therapy) by health workers or their families at home (within 30 days) or routinely for intravenous therapy such as hemodialysis or chemotherapy (within 30 days) (Cardoso et al., 2014) . Patients are exposed to HCAI if the first day of hospitalization does not get an infection, then the patient gets an infection after 72 hours of hospitalization (Taylor et al., 2016) . A. baumannii is one of the causes of HCAI and usually these bacteria have become MDR bacteria. Data reported from the results of the 20 provincial studies in Thailand MDR A. baumanni this caused the community acquired bacteremia by 28%, healthcare associated with bacteremia 50% and 75% hospital acquired bacterimia (p <0.001) (Lim et al., 2016) .
Carbapenem (meropenem, doripenem, imipenem, and ertapenem) is one of the recommended antibiotic groups to address the MDR A. baumannii (Lei et al., 2016) . However, the resistance rate of A. baumannii to carbapenem continues to increase. Data from the study conducted at neonatal unit of RS Dr. Cipto Mangunkusumo Jakarta, obtained only 16% of A. baumanni (n = 24) isolates which were still sensitive to carbapenem antibiotics, where the isolates from 100% blood were MDR A. baumannii and isolates originating from the environment around the patient in care 82 % was MDR A. baumannii (Tjoaet al., 2013) .
Preliminary study conducted in RS Dr. Moewardi Surakarta on the existence of Carbapenem Resistant Acinetobacterbaumannii (CRAB) had been done by researchers. Data from the results of the antibiotic resistance test of carbapenem at A. baumannii, during September-October 2016, obtained 58.8% isolates were still sensitive to carbapenem and 41.1% of isolates had been resistant to carbapenem (n = 102). This required comprehensive study and follow-up because of the high resistance rate of A.baumanni, almost 50%, which made the therapeutic choice narrower and could increase mortality and morbidity.
Patients hospitalized for more than 48 hours and located in intensive care unit (ICU) care facilities or other similar intensive care have been generally exposed to some previousantibiotics. The patient, treated with one or more pre-existing comorbid conditions, has a low functional status, can not undergo daily activities well and often needs other's help. The patient's performance or functional status as measured by the Karnofsky Scale (Karnofsky Index) can provide a clinical picture of the patient's condition and the prognosis of the patient associated with the illness, when the patient has a karnofsky score <70 means that the patient is unable to perform normal activities, the lower the score, the worse the prognosis and higher mortality (Cardoso et al., 2012; Peuset al., 2013; Kelly and Shahrokni, 2016) Procurement of antibiotic susceptibility tests against specimens from patients suspected of having HCAI with comorbid conditions and low patient functional status should be a routine agenda at a hospital. Based on the above exposure, the researchers are interested in conducting study on the factors causing Acinetobacterbaumannii resistance to carbapenem antibiotics in patients with HCAI in RS Dr. Moewardi Surakarta. 
SUBJECTS

RESULTS
A. Univariate Analysis
Study subject characteristic included gender, age, treatment room and specimen type shown in Table 1 and Table 2 . Based on both tables it was found that from 104 major study subjects were male (54%). More than half of the study subjects were in the range age of 46-65 years (50.9%) and the rate age was 47 years. Subject majority treated in the care ward at Dr. Moewardi Hospital, were in the Orchid 1 ward (26.9%) and the least was from the NICU ward (0.9%).
When viewed from the specimen type, the majority of specimens came from sputum (68.2%) and the least were bronchial aspirate and pleural specimens respectively of only 0.9%. Based on the functional status score of the patient as measured by PPP, the study subjects had a minimum value of 10 and a maximum of 60 with an average of 38.75 and a median of 40.
While patient comorbid conditions were measured by CCI, the study subjects had a minimum score of 0 and a maximum of 10 with an average of 2.03. Table 3 showed an odds ratio of 6.76 meaning that patients with a history of inadequately empirical antibiotic therapy had a 6.76 times greater possibility of triggering CRAB in patients with HCAI.
Chi-Square test results showed that there was an influence of previous history of antibiotic use with CRAB in patients with HCAI and statistically significant (p = 0.001). Lin and Lan's (2014) study also mentioned the same that previous antibiotic use was an independent risk factor for resistance to Acinetobacterbaumannii. Kim et al., (2012) suggested that a previous history of high antibiotic use along with several other factors was an independent risk factor for CRAB. It had also been reported by Camp and Tatum (2010) in theirstudy, which the study mentioned that one of the factors that influenced the formation of Acinetobacterbaumannii resistance was due to the use of various antibiotics before. Use of antibiotics as an extensive therapy regimen is also a cause of Acinetobacterbaumannii resistance to carbapenem and other antibiotics (Bialvaei et al., 2017) .
A study conducted by Peleq et al. (2008) showed that antibiotic treatment for infection therapy caused by Acinetobacterbaumannii incorrectly triggered both enzymatic and non enzymatic activity of the bacteria to resist, so that bacteria had innate resistance to be resistant to certain antibiotics. Many other studies also suggest that Acinetobacterbaumannii has a complex intrinsic ability to withstand the effects of antibiotics and eventually become resistant (Peleq et al., 2008; Camp et al., 2010; Giedraitiene et al., 2011; Khaldi et al., 2017 ; Bialvaei et al., 2017) .
Use of antibiotics suitable for the treatment of bacterial infections empirically and definitively is absolutely necessary to control the existence of resistance and maintain antibiotic sustainability as a therapeutic regimen, as we know that the process of making and antibiotic modification for therapy requires a considerable cost and a long time. Yoon et al., (2104) conducted a study of the carbapenem antibioticuse against infections caused by Acinetobacterbaumannii, the study conducted with an Acinetobacterbaumannii infection control program with the regulation of the administration of the main empirical antibiotic (drug of choice) group 1 carbapenem (ertapenem) and group 2 (imipenem and meropenem) was divided into three phases of therapy. The study proved that the appropriate use of empirical or definitive antibiotics will be able to control the spread of Acinetobacterbaumannii infection and prevent its resistance to carbapenem as a drug of choice.
Carbapenem-resistant acinetobacterbaumannii is generally also resistant to two or more other antibiotics, especially betalactam antibiotics, and the researchers also found a similar phenomenon in this study (Peleqet al., 2008; Camp et al., 2010; Lin and Lan, 2014; Khaldiet al., 2017; Bialvaei et al., 2017) . Therefore Acinetobacterbaumannii is also a multi drug resistant (MDR) or even excessively drug resistant Acinetobacterbaumannii (XDRAB) due to its resistance to colistin in addition to its resistance to other antibiotics in the list of Acinetobacterbaumannii (Lin and Lan, 2014) MDR, but in this study it did not find any XDRAB.
Antimicrobial stewardship program is really important to do not only in hospital environment but also in the society because the development and spread of CRAB is high enough in various parts of the world which resulted in increasing morbidity and mortality rate as well as the increase of health cost which becomes society and state burden (Yoon et al., 2104; Zowawi et al., 2015) .
Functional Status affected Patients on Acinetobacterbaumannii Resistance to Carbapenem (CRAB) in Patients with Healthcare-Associated Infections (HCAI)
The study results showed a significant effect (p<0.001) between the patient's functional status against Acinetobacterbaumannii resistance to carbapenem (CRAB) in patients with HealthcareAssociated Infections (HCAI). This is based on Cardoso's et al., (2012) The cohort study conducted by Chang et al. (2015) in Taiwan also supported the results of this study. The study was conducted on patients treated in long term care facilities (LTCFs) who suffered from bacterial infection, and one conclusion from the study that lower functional status (measured by PPP) was a significant predictive factor in all infections leading to death in LTCFs. The most common cases of LTCFs were urinary tract infection (41.7%), lower respiratory tract infection (32.1%) and infection of skin or soft tissue (27.6%), whereas in the study most cases were lower respiratory tract infection (68.2%), skin and soft tissue infections (13.5%) and bacteremia and/ or sepsis (8.6%). Other studies also suggested that functional disability is a risk factor for the occurrence of MDC Acinetobacterbaumannii colonization in patients (Modyet al., 2015) .
Measuring the patient's functional status is important to determine the patient's condition regarding the prognosis and survival of the patient including knowing the severity of the disease and patient'snext disease end consequence (Lee et al., 2006; Carey et al., 2008) . The lower the functional status of the patient, the worse the condition and the prognosis of the patient, in this study it is evident that the lower functional status of the patient has a significant effect on the occurrence of Acinetobacterbaumannii resistance to carbapenem antibiotics. Acinetobacterbaumannii is a bacterium that has the ability to survive high hospital environments and has intrinsic ability to resist the antibiotics exposed to it, so when the patient has a low functional condition, it becomes easier for Acinetobacterbaumannii to cause resistance and worsen the patient's prognosis.
In this study, it was also found cases which the patient first examined for bacterial culture and antibiotic sensitivity test showed the results of Acinetobacterbaumanni that was not resistant to carbapenem, but on the next test a few days later, Acinetobacterbaumannii had become resistant to carbapenem, the case occurred in patients with the PPP score in Category III. The average PPP score in this study was 38.75%, and the patients in category III in the KPS not being able to care for themselves required hospital care and the disease could experience rapid development (high disease progression). The findings of this study are consistent with previous studies where low PPPs contribute significantly to bacterial infection leading to higher patient mortality and a poorer prognosis and lower survival (Looney et al., 2003; Lee et al. , 2006; Carey et al., 2008; Chang et al., 2015) .
Effect of Treatment on Intensive Units against
Acinetobacterbaumannii Resistance to Carbapenem (CRAB) in Patients with HealthcareAssociated Infections (HCAI)
This study showed that treatment at the Intensive Unit increased the Acinetobacterbaumannii resistance to carbapenem (CRAB) in patients with Healthcare-Associated Infections (HCAI) although it was statistically insignificant. A study supporting the results of this study was a study conducted by Liu et al. (2015) , one of the independent risk factors for the occurrence of bacteremia caused by MDR Acinetobacterbaumannii was the patient's care ward in ICU. A study conducted by Uwingabiye, et al (2015) also explained that the number of patients admitted to the ICU infected with CRAB MDR was higher than that treated in the ward (non ICU) with a significant difference (p<0.001). The results of an international study conducted in 2007 on infections in 1265 ICUs from 75 different countries concluded that patients treated in ICU for a long time may have increased the risk of bacterial infections especially those resistant to antibiotics, one of which was Acinetobacter bacteria (Radji et al., 2011) .
The use of invasive respiratory aids such as ventilators is high enough in intensive units, Acinetobacterbaumanniiis commonly found in various ventilator surfaces causing patients to have ventilator associated pneumonia (VAP), the majority of isolates from intensive units in this study were sputum, and the final diagnostic conclusion is VAP -Pneumonia bacterial etcausaAcinetobacterbaumannii.
Study Tsakiridou et al. (2014) concluded that Acinetobacterbaumannii infection in patients treated in ICU is an independent risk factor for VAP events. Patients treated with long-term ICU ventilators are important risk factors for the occurrence of Acinetobacterbaumannii MDR (Arvaniti et al., 2012) .
Most of bacterial infection outbreaks occurs in many ICUs and may trigger the occurrence of bacterial resistance epidemics (Vlek et al., 2013; Cheonet al., 2016) . ICU generally contains patients with critical conditions requiring extended intensive and invasive treatment periods, putting patients at risk of infection. Existing bacteria in the ICU environment are opportunistic bacteria, causing no infection in healthy humans only colonization, but for these bacterial patients to be highly pathogenic causing therapeutic difficulty and longer treatment periods and high cost increases (Dijkshoorn et al. 2007) . Duijn and Bonten (2014) mentioned that ICU is the center of the birth of antibiotic-resistant Gram-negative bacteria (ARGNB) resistance to antibioticresistant bacteria (ARGNB) due to high antibiotic usage, immunological factors of patients in acute periods appropriate for bacterial infection and close contact by health workers with patients who facilitate cross-bacterial transmission. One of the gram-negative bacteria that is opportunistic then becomes highly pathogenic is Acinetobacterbaumannii, which triggers the infection outbreak in the hospital because the ability of colonization on the human body and the environment is very high (Dijkshoorn et al., 2007; Mamminaet al., 2012; Duijn and Bonten, 2014; Uwingabiye et al., 2015; Taggart et al., 2015) .
Influence of Comorbid Conditions on Acinetobacterbaumannii Resistance to Carbapenem (CRAB) in Patients with Healthcare-Associated Infections (HCAI)
This study showed that patients with high comorbid conditions increased the risk of Acinetobacterbaumannii resistance to carbapenem (CRAB) in patients with Healthcare-Associated Infections (HCAI) although it was not statistically significant. Study conducted by Lee, et al. (2004) suggested that the comorbid condition of patients is a risk factor for the occurrence of carbapenem-resistant Acinetobacterbaumannii (imipenem). A similar study was also conducted by Ye et al., (2010) which stated that the comorbid condition of patients is a risk factor for the occurrence of MDR Acinetobacterbaumannii, specifically resistant to immune receptor (Imipenem Resistant MDR Acinetobacterbaumannii (IR-MDRAB). Comorbid condition was concluded as one of the predictors for the risk of bacteremia caused by Acinetobacterbaumannii in patients treated in ICU, which CRAB in the same study was also a strong predictor factor for high mortality in patients (Shorr et al., 2014) .
According to study Chopra et al. (2013) comorbid conditions in patients also affect the occurrence of carbapenem and ampicillinsulbactam resistant (CASR) Acinetobacterbaumannii. Other studies have suggested that comorbid conditions are also independent risk factors for bacteremia caused by Acinetobacterbaumannii (Chopra et al., 2014) . Conclusions from the study of Verseleset al. (2013) , among others, patients with high comorbidity based on the Charlson Comorbidity Index and accompanied by colonization of MDR bacteria may increase the risk of patients being admitted to intensive units. Other studies also suggest that the patient's condition with high comorbidities also increases the patient death risk (low survival) infected by Acinetobacterbaumannii (Ballouz et al., 2017) .
Most of patients hospitalized in Dr. Moewardi hospital have more than one comorbid condition, especially if the patient is in the elderly age range, so at the time of this study, many patients had high comorbid conditions but were not infected by CRAB. This does not rule out that patients with high comorbid conditions will be infected with CRAB, because researchers found cases of patients who was initially infected byAcinetobacterbaumannii and still sensitive to carbapenem but on checking patient's culture it had been infected by CRAB. Patients who experience bacteremia caused by CRAB are generally in a chronic condition of a disease, high severity illness, high comorbidity and high mortality (Estherlyet al., 2011) .
This study is the first CRAB study in Surakarta in HCAI patients and similar data in Indonesia is very limited, although this study also has limitations. The sample size in this study was 104 whereas the multivariate analysis chosen was multiple logistic regression analysis requiring large samples. Researchers only make suffice of 104 samples because the study duration has exceeded the time period of study (5 months to collect samples) and time constraints possessed by researchers during the study.
Acinetobacterbaumannii colonization in patients can be misinterpreted as patients in the control group, in this study the researchers can not distinguish these two things. To overcome this, a surveillance of prospective and periodic Acinetobacterbaumannii infection in the hospital areneeded.
Based on the results of the above study it can be concluded that the history of previous antibiotic conformity and functional status of patients is a factor that affects the occurrence of Acinetobacterbaumannii resistance to carbapenem (CRAB) in patients with Healthcare-Associated Infections (HCAI).
